Micropore Technologies Announced as a Winner in Heathrow Airport’s Global Britain Business Champion Competition
Micropore Technologies is a global business that has spent many hundreds of hours travelling across the world from London’s Heathrow Airport over recent years. This award recognises the pioneering role that this UK-based company is playing on the global stage, where its particle engineering expertise is deployed in the production of the lipid nanoparticles such as those found in the COVID-19 vaccine. Micropore’s technology stands to revolutionise the manufacture of a wide range of future pharmaceutical products.
From Japan to California and 30 countries in between, Micropore has found that there is demand right across the world for the biopharmaceutical standard, high-throughput technology it has developed. This technology offers the capability of producing mRNA vaccines and long acting, controlled release drugs under precise control. Micropore’s uniform and tailored drug particle sizes are not only suitable for early-stage development but also the manufacturing of delicate pharmaceutical formulations at much higher volumes – all with a saving of over 85% energy compared with other processes and without destroying fragile materials such as mRNA. Micropore is hopeful that its technology for making products less expensively, using less energy and with zero waste, will be a game changer in global pharmaceutical manufacturing.
“We are delighted with the recognition of the role that a relatively young business like ourselves is playing on behalf of British industry, on the world stage. We are pioneers in our field and the international connections that a global hub like Heathrow Airport provides has been critical to our expansion and our ability to be able to service our customers worldwide,” said Dai Hayward, CEO, Micropore Technologies.
Micropore’s patented encapsulation technology originated in the department of chemical engineering at Loughborough University. Dr Marijana Dragosavac Senior Lecturer and Undergraduate Admissions Tutor at Chemical Engineering department at Loughborough and Micropore’s Chief Scientific Officer has published many papers in the field. Micropore Technologies Limited was established over 10 years ago as a high-technology spin-out of Loughborough University and is a solutions provider commercializing products and technology based on its patented encapsulation and emulsification processes. For more information, visit www.microporetech.com.
Total Page Views: 1100
